{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:49:47Z","timestamp":1769269787957,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2011\/23781-2"],"award-info":[{"award-number":["2011\/23781-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Conselho Nacional de Ci\u00eancia e Tecnologia","award":["301805\/2013-0"],"award-info":[{"award-number":["301805\/2013-0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00198-018-4629-z","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T21:58:37Z","timestamp":1531519117000},"page":"2565-2573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Monocytes from male patients with ankylosing spondylitis display decreased osteoclastogenesis and decreased RANKL\/OPG ratio"],"prefix":"10.1007","volume":"29","author":[{"given":"V.F.","family":"Caparbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.S.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"de Brum-Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-5028","authenticated-orcid":false,"given":"R.M.R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"issue":"4","key":"4629_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K (2007) Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22(4):487\u2013494","journal-title":"J Bone Miner Res"},{"key":"4629_CR2","unstructured":"Sprangers S, de Vries TJ, Everts V (2016) Review article: monocyte heterogeneity: consequences for monocyte-derived immune cells. J Immunol Res 1475435"},{"issue":"6","key":"4629_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/jcp.25220","volume":"231","author":"S Sprangers","year":"2016","unstructured":"Sprangers S, Schoenmaker T, Cao Y, Everts V, de Vries TJ (2016) Different blood-borne human osteoclast precursors respond in distinct ways to IL-17A. J Cell Physiol 231(6):1249\u20131260","journal-title":"J Cell Physiol"},{"issue":"2","key":"4629_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.imbio.2014.08.007","volume":"220","author":"H Xiong","year":"2015","unstructured":"Xiong H, Pamer EG (2015) Review article: monocytes and infection: modulator, messenger and effector. Immunobiology 220(2):210\u2013214","journal-title":"Immunobiology"},{"issue":"1\u20133","key":"4629_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","volume":"53","author":"KL Wong","year":"2012","unstructured":"Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM, Wong SCL (2012) The three human monocyte subsets: implications for health and disease. Immunol Res 53(1\u20133):41\u201357","journal-title":"Immunol Res"},{"key":"4629_CR6","first-page":"620","volume":"27","author":"CH Im","year":"2009","unstructured":"Im CH, Kang EH, Ki JY, Shin DW, Choi HJ, Chang EJ, Lee EY, Lee YJ, Lee EB, Kim HH, Song YW (2009) Receptor activator of nuclear factor kappa B ligand mediated osteoclastogenesis is elevated in ankylosing spondylitis. Clin Exp Rheumatol 27:620\u2013625","journal-title":"Clin Exp Rheumatol"},{"key":"4629_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bionut.2012.10.013","volume":"3","author":"M Colina","year":"2013","unstructured":"Colina M, Penolazzi L, DI Ciano M, Lambertini E, Ciancio G, Orzincolo C, Trotta F, Govoni M, Piva R (2013) Osteoclasts from peripheral blood mononuclear cells culture of ankylosing spondylitis subjects are resistant to apoptosis. Biom Prev Nutr 3:253\u2013259","journal-title":"Biom Prev Nutr"},{"issue":"9783","key":"4629_CR8","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137","journal-title":"Lancet"},{"issue":"3","key":"4629_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","volume":"38","author":"RJ Lories","year":"2012","unstructured":"Lories RJ, Schett G (2012) Pathophysiology of new bone formation and ankylosis in spondyloarthritis. Rheum Dis Clin N Am 38(3):555\u2013567","journal-title":"Rheum Dis Clin N Am"},{"issue":"12","key":"4629_CR10","first-page":"2832","volume":"7","author":"HJ Singh","year":"2013","unstructured":"Singh HJ, Nimarpreet K, Ashima DS, Kumar A, Prakash S (2013) Study of bone mineral density in patients with ankylosing spondylitis. J Clin Diagn Res 7(12):2832\u20132835","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"4629_CR11","doi-asserted-by":"publisher","first-page":"e000052","DOI":"10.1136\/rmdopen-2015-000052","volume":"14","author":"K Briot","year":"2015","unstructured":"Briot K, Roux C (2015) Review article: inflammation, bone loss and fracture risk in spondyloarthritis. RMD Open 14(1):e000052","journal-title":"RMD Open"},{"issue":"3","key":"4629_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11914-011-0058-z","volume":"9","author":"S Carter","year":"2011","unstructured":"Carter S, Lories RJ (2011) Osteoporosis: a paradox in ankylosing spondylitis. Curr Osteoporos Rep 9(3):112\u2013115","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"4629_CR13","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/art.21907","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S, K\u00f6hler D, Zacher J, Stein H, Sieper J, Loddenkemper C (2006) Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum 54(6):1805\u20131813","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4629_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/ar2642","volume":"11","author":"RJ Lories","year":"2009","unstructured":"Lories RJ, Luyten FP, de Vlam K (2009) Progress in spondyloarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 11(2):221","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"4629_CR15","doi-asserted-by":"publisher","first-page":"e0144655","DOI":"10.1371\/journal.pone.0144655","volume":"10","author":"In\u00eas P. Perp\u00e9tuo","year":"2015","unstructured":"Perp\u00e9tuo IP, Raposeiro R, Caetano-Lopes J, Vieira-Sousa E, Campanilho-Marques R, Ponte C, Canh\u00e3o H, Ainola M, Fonseca JE (2015) Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis. PLoS One (10, 12):e0144655","journal-title":"PLOS ONE"},{"key":"4629_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"4629_CR17","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landew\u00e9 R, Maksymowych W, van der Heijde (2009) The assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013i44","journal-title":"Ann Rheum Dis"},{"key":"4629_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D (2011) Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47\u201353","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4629_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers MC, Franssen MJ, Van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64(1):127\u2013129","journal-title":"Ann Rheum Dis"},{"issue":"49","key":"4629_CR20","doi-asserted-by":"publisher","first-page":"49271","DOI":"10.1074\/jbc.M309914200","volume":"278","author":"MF Manolson","year":"2003","unstructured":"Manolson MF, Yu H, Chen W, Yao Y, Li K, Lees RL, Heersche JN (2003) The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (>or=10 nuclei) and small (<or= nuclei) osteoclasts. J Biol Chem 278(49):49271\u201349278","journal-title":"J Biol Chem"},{"issue":"3","key":"4629_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.bone.2010.10.167","volume":"48","author":"M Durand","year":"2011","unstructured":"Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ (2011) The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis\u2014the In Vitro Osteoclast Differentiation in Arthritis (IODA) study. Bone 48(3):588\u2013596","journal-title":"Bone"},{"issue":"1","key":"4629_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/art.37722","volume":"65","author":"M Durand","year":"2013","unstructured":"Durand M, Komarova SV, Bhargava A, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ (2013) Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study. Arthritis Rheum 65(1):148\u2013158","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4629_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/03009740802116224","volume":"37","author":"P Spelling","year":"2008","unstructured":"Spelling P, Bonf\u00e1 E, Caparbo VF, Pereira RM (2008) Osteoprotegerin\/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? Scand J Rheumatol 37(6):439\u2013444","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"4629_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00198-014-2860-9","volume":"26","author":"LP Seguro","year":"2015","unstructured":"Seguro LP, Casella CB, Caparbo VF, Oliveira RM, Bonfa A, Bonfa E, Pereira RM (2015) Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients. Osteoporos Int 26(2):459\u2013467","journal-title":"Osteoporos Int"},{"key":"4629_CR25","volume-title":"Generalized, linear and mixed models","author":"CE MCculluch","year":"2001","unstructured":"MCculluch CE, Searle SR (2001) Generalized, linear and mixed models. Wiley, New York"},{"issue":"9","key":"4629_CR26","first-page":"1214","volume":"16","author":"JJ Dubost","year":"1989","unstructured":"Dubost JJ, Sauvezie B (1989) Late onset peripheral spondyloarthropathy. J Rheumatol 16(9):1214\u20131217","journal-title":"J Rheumatol"},{"issue":"3","key":"4629_CR27","first-page":"419","volume":"55","author":"C Webers","year":"2016","unstructured":"Webers C, Essers I, Ramiro S, Stolwijk C, Landew\u00e9 R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A (2016) Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. Rheumatology (Oxford) 55(3):419\u2013428","journal-title":"Rheumatology (Oxford)"},{"key":"4629_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s11657-015-0214-7","volume":"10","author":"HL Runolfsdottir","year":"2015","unstructured":"Runolfsdottir HL, Sigurdsson G, Franzson L, Indridason OS (2015) Gender comparison of factors associated with age-related differences in bone mineral density. Arch Osteoporos 10:214","journal-title":"Arch Osteoporos"},{"issue":"10","key":"4629_CR29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10067-010-1543-y","volume":"29","author":"CH Chen","year":"2010","unstructured":"Chen CH, Chen HA, Liao HT, Liu CH, Tsai CY, Chou CT (2010) Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Clin Rheumatol 29(10):1155\u20131161","journal-title":"Clin Rheumatol"},{"issue":"7","key":"4629_CR30","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3899\/jrheum.131199","volume":"41","author":"E Klingberg","year":"2014","unstructured":"Klingberg E, Nurkkala M, Carlsten H, Forsblad-d'Elia H (2014) Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis. J Rheumatol 41(7):1349\u20131356","journal-title":"J Rheumatol"},{"issue":"11","key":"4629_CR31","first-page":"2236","volume":"31","author":"H Franck","year":"2004","unstructured":"Franck H, Meurer T, Hofbauer LC (2004) Evaluation of bone mineral density, hormones,biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31(11):2236\u20132241","journal-title":"J Rheumatol"},{"issue":"4","key":"4629_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10067-007-0726-7","volume":"27","author":"L Goh","year":"2008","unstructured":"Goh L, Suresh P, Gafoor A, Hughes P, Hickling P (2008) Disease activity in longstanding ankylosing spondylitis: a correlation of clinical and magnetic resonance imaging findings. Clin Rheumatol 27(4):449\u2013455","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4629_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/BOR.0b013e328133f57b","volume":"19","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Wendling D (2007) Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis. Curr Opin Rheumatol 19(4):340\u2013345 Review","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"4629_CR34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","volume":"31","author":"MA Weijden van der","year":"2012","unstructured":"van der Weijden MA, Claushuis TA, Nazari T, Lems WF, Dijkmans BA, van der Horst-Bruinsma IE (2012) High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol 31(11):1529\u20131535","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4629_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semarthrit.2016.03.003","volume":"46","author":"MN Magrey","year":"2016","unstructured":"Magrey MN, Lewis S, Asim Khan M (2016) Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis\u2014a prospective study. Semin Arthritis Rheum 46(1):88\u201394","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4629_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3899\/jrheum.130803","volume":"41","author":"A Surdacki","year":"2014","unstructured":"Surdacki A, Sulicka J, Korkosz M, Mikolajczyk T, Telesinska-Jasi\u00f3wka D, Klimek E, Kierzkowska I, Guzik T, Grodzicki TK (2014) Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis. J Rheumatol 41(3):481\u2013489","journal-title":"J Rheumatol"},{"key":"4629_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/ard.2005.037465","volume":"65","author":"RJ Francois","year":"2006","unstructured":"Francois RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumor necrosis factor a in two patients with early disease and transforming growth factor b in three more advanced cases. Ann Rheum Dis 65:713\u2013720","journal-title":"Ann Rheum Dis"},{"key":"4629_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kem098","volume":"46","author":"H Marzo-Ortega","year":"2007","unstructured":"Marzo-Ortega H, O'Connor P, Emery P, MCgonagle D (2007) Sacroiliac joint biopsies in early sacroilitis. Rheumatol 46:1210\u20131211","journal-title":"Rheumatol"},{"key":"4629_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3109\/s10165-008-0149-6","volume":"19","author":"M Kawashima","year":"2009","unstructured":"Kawashima M, Fujikawa Y, Itonaga I, Takita C, Tsumura H (2009) The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro. Mod Rheumatol 19:192\u2013198","journal-title":"Mod Rheumatol"},{"issue":"11","key":"4629_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/0022034509346147","volume":"88","author":"A Karakawa","year":"2009","unstructured":"Karakawa A, Fukawa Y, Okazaki M, Takahashi K, Sano T, Amano H, Yamamoto M, Yamada S (2009) Diclofenac sodium inhibits NFkappaB transcription in osteoclasts. J Dent Res 88(11):1042\u20131047","journal-title":"J Dent Res"},{"issue":"5","key":"4629_CR41","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/ph3051394","volume":"3","author":"S Kotake","year":"2010","unstructured":"Kotake S, Yago T, Kawamoto M, Nanke Y (2010) Review article: Effects of NSAIDs on differentiation and function of human and murine osteoclasts\u2014crucial \u2018human osteoclastology\u2019. Pharmaceuticals (Basel) 3(5):1394\u20131410","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"4629_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/187152809788681065","volume":"8","author":"P Salari","year":"2009","unstructured":"Salari P, Abdollahi M (2009) Review article: controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Targets 8(3):169\u2013175","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"4","key":"4629_CR43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbrc.2007.04.058","volume":"357","author":"A Nakao","year":"2007","unstructured":"Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K (2007) RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways. Biochem Biophys Res Commun 357(4):945\u2013950","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"4629_CR44","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00296-011-2066-9","volume":"32","author":"S Grazio","year":"2012","unstructured":"Grazio S, Kusi\u0107 Z, Cvijeti\u0107 S, Grubi\u0161i\u0107 F, Balenovi\u0107 A, Nem\u010di\u0107 T, Matijevi\u0107-Mikeli\u0107 V, Punda M, Sieper J (2012) Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 32(9):2801\u20132808","journal-title":"Rheumatol Int"},{"issue":"1","key":"4629_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.rhu.0000255688.83037.42","volume":"13","author":"S Sarikaya","year":"2007","unstructured":"Sarikaya S, Basaran A, Tekin Y, Ozdolap S, Ortancil O (2007) Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol 13(1):20\u201324","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"4629_CR46","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, Heijde DV, Landew\u00e9 R, B\u00e9hier JM, Calin A, Olivieri I, Zeidler H, Dougados M (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52(6):1756\u20131765","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4629_CR47","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71(10):1616\u20131622","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4629_CR48","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3899\/jrheum.121417","volume":"40","author":"A Durnez","year":"2013","unstructured":"Durnez A, Paternotte S, Fechtenbaum J, Landew\u00e9 RB, Dougados M, Roux C, Briot K (2013) Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. J Rheumatol 40(10):1712\u20131718","journal-title":"J Rheumatol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4629-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4629-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4629-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T20:32:17Z","timestamp":1589920337000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4629-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4629"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4629-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"26 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Local Ethics Committee on Human Research at the Sao Paulo University-CAPPesq 0061\/11.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Valeria F. Caparbo, Carla GS Saad, Julio CB Moares, Artur J de Brum-Fernandes, and Rosa MR Pereira declare no conflicts of interest and no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}